QL-415

N/A

Report date: 2022/02/16 09:57:50

Base Information

Drug NameQL-415
Drug Alias NameQL-415
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 receptor subunit alpha agonistsProgrammed death-ligand 1 blockers
TargetsInterleukin-15 receptor subunit alphaProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesQlsf Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQlsf Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A